RxDoctor Payments Data

Josh White

Medical · Appleton, WINPI 1063478055

Payments from drug & device makers

What this record shows

27 manufacturers reported payments, led by GE HealthCare at 51.2% of the total. Reporting peaked in 2023 at $1,869 and has fallen 82.0% since, to $336 in 2025. Among medical clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,113in general payments, 2019–2025

Across 80 payments — averaging $38.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GE HealthCare$2K
  • Novartis$330
  • Abbott$128
  • Medtronic$126
  • Alnylam Pharmaceuticals Inc.$97
  • AstraZeneca$91
  • plus $747 from 21 others

What the payments were for

  • Consulting fees$1,59551%
  • Food & beverage$1,51849%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,113 in reported general payments places this provider in the 90th percentile of 247 medical providers in Wisconsin.

See all medical providers in Wisconsin

Medicare billing

Part B allowed, 2024
$9,550
Medicare patients
129
Services billed
455

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban99$127,166
EntrestoSacubitril/Valsartan46$39,984
XareltoRivaroxaban29$27,417
Dofetilide82$12,406
BrilintaTicagrelor24$12,365
JardianceEmpagliflozin12$10,895
Metoprolol Succinate115$2,167
Flecainide Acetate29$1,149
Potassium Chloride64$1,048
Metoprolol Tartrate91$1,028
SotalolSotalol Hcl40$912
Amiodarone Hcl44$636
Diltiazem 24hr Er (Cd)Diltiazem Hcl24$544
Furosemide80$503
Eplerenone12$440

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$85$127,16699 claims
NovartisEntresto$330$39,98446 claims
Johnson & JohnsonXarelto$70$27,41729 claims
AstraZenecaBrilinta$91$12,36524 claims
Boehringer IngelheimJardiance$31$10,89512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 247 medical providers in Wisconsin.

Other medical in Appleton

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →